Hargreaves Lansdown investors are buying Darktrace shares. Should I buy too?

Last week, UK investors piled into Darktrace shares. Edward Sheldon looks at whether he should buy the cybersecurity stock for his own portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in cybersecurity specialist Darktrace (LSE: DARK) are popular at the moment. Last week, for example, DARK was the fifth most purchased stock on Hargreaves Lansdown’s platform.

I’m quite bullish on the prospects for the cybersecurity sector as a whole. Going forward, cybercrime is only going to become more of a problem and businesses and governments are going to spend billions fighting it. Should I buy Darktrace shares for my portfolio then? Let’s take a look.

Should I buy Darktrace shares?

The first thing I want to know about Darktrace is whether the company has a genuine competitive advantage. There are plenty of great cybersecurity companies I could invest in today (Crowdstrike, ZScaler, etc). Is Darktrace an industry leader?

Looking at reviews of Darktrace’s cybersecurity solutions, I’m not 100% certain it’s a genuine industry leader. Gartner, for example, gives Darktrace a score of 4.4/5 while it gives Crowdstrike 4.9/5. Meanwhile, on software review site TrustRadius, Darktrace has a score of 8.7/10 while Crowdstrike has a score of 9.1/10.

I know this is a simplistic way of assessing competitive advantage but I think it’s helpful. These reviews indicate that there could potentially be better cybersecurity stocks to buy if I’m looking to invest in the best companies.

Strong growth

Turning to the financials, I’m impressed by Darktrace’s growth. Recent full-year results for the year ended 30 June showed revenue growth of 41.3%. Adjusted EBITDA for the period was up 233% to $29.7m.

There were plenty of other positives in the full-year results too. For example, the group recorded a 45.3% year-on-year increase in customers. It also upgraded its FY2022 guidance. For the year ending 30 June 2022, it now expects year-on-year revenue growth of between 35% and 37%, versus previous guidance of 29-32%.

It’s worth pointing out however, that there are other cybersecurity companies growing faster than Darktrace. Crowdstrike, for example, generated revenue growth of 74% over the 12 months to 30 June, according to my calculations. And over the next 12 months, Wall Street analysts expect top-line growth of around 46% from the company.

3 risks that could hit the Darktrace share price

Looking at the risks here, there are a few that stand out to me. One’s the fact that the company is unprofitable. The full-year results showed a net loss of $149.6m (up from $28.7m a year earlier). This is not a deal-breaker for me because it’s quite common for high-growth tech companies to be unprofitable in their early days. But it does add risk.

Another is that founder and majority shareholder Mike Lynch is facing extradition to the US on fraud charges.

A third risk is the valuation. Currently, Darktrace sports a forward-looking price-to-sales ratio of 31. That’s high. If growth slows, the share price could fall. Having said that, the valuation here’s well below that of Crowdstrike, which has a price-to-sales ratio of 53.

DARK shares: my move now

Weighing everything up, I’m going to keep Darktrace shares on my watchlist for now. The company certainly looks interesting. However, I think there are better growth stocks to buy right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares of Hargreaves Lansdown. The Motley Fool UK owns shares of and has recommended CrowdStrike Holdings, Inc. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »